Logo image of MSTR

MICROSTRATEGY INC-CL A (MSTR) Stock Fundamental Analysis

NASDAQ:MSTR - Nasdaq - US5949724083 - Common Stock - Currency: USD

434.58  +12.84 (+3.04%)

After market: 433.3 -1.28 (-0.29%)

Fundamental Rating

2

Overall MSTR gets a fundamental rating of 2 out of 10. We evaluated MSTR against 282 industry peers in the Software industry. MSTR has a bad profitability rating. Also its financial health evaluation is rather negative. MSTR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MSTR was profitable.
In the past year MSTR has reported a negative cash flow from operations.
In the past 5 years MSTR reported 4 times negative net income.
Of the past 5 years MSTR 4 years had a positive operating cash flow.
MSTR Yearly Net Income VS EBIT VS OCF VS FCFMSTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B -15B -20B

1.2 Ratios

MSTR has a Return On Assets of -12.16%. This is in the lower half of the industry: MSTR underperforms 63.12% of its industry peers.
MSTR has a Return On Equity (-15.93%) which is in line with its industry peers.
Industry RankSector Rank
ROA -12.16%
ROE -15.93%
ROIC N/A
ROA(3y)-18.83%
ROA(5y)-14.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MSTR Yearly ROA, ROE, ROICMSTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

With a Gross Margin value of 70.95%, MSTR perfoms like the industry average, outperforming 56.03% of the companies in the same industry.
In the last couple of years the Gross Margin of MSTR has declined.
MSTR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-1.93%
MSTR Yearly Profit, Operating, Gross MarginsMSTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

MSTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MSTR has been increased compared to 1 year ago.
Compared to 5 years ago, MSTR has more shares outstanding
The debt/assets ratio for MSTR has been reduced compared to a year ago.
MSTR Yearly Shares OutstandingMSTR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
MSTR Yearly Total Debt VS Total AssetsMSTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 6.86 indicates that MSTR is not in any danger for bankruptcy at the moment.
MSTR's Altman-Z score of 6.86 is fine compared to the rest of the industry. MSTR outperforms 75.53% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that MSTR is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.24, MSTR perfoms like the industry average, outperforming 43.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 6.86
ROIC/WACCN/A
WACC10.75%
MSTR Yearly LT Debt VS Equity VS FCFMSTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B -20B

2.3 Liquidity

MSTR has a Current Ratio of 0.66. This is a bad value and indicates that MSTR is not financially healthy enough and could expect problems in meeting its short term obligations.
MSTR's Current ratio of 0.66 is on the low side compared to the rest of the industry. MSTR is outperformed by 86.17% of its industry peers.
MSTR has a Quick Ratio of 0.66. This is a bad value and indicates that MSTR is not financially healthy enough and could expect problems in meeting its short term obligations.
MSTR has a worse Quick ratio (0.66) than 86.17% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66
MSTR Yearly Current Assets VS Current LiabilitesMSTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

MSTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 202.05%, which is quite impressive.
Looking at the last year, MSTR shows a decrease in Revenue. The Revenue has decreased by -6.19% in the last year.
Measured over the past years, MSTR shows a decrease in Revenue. The Revenue has been decreasing by -0.96% on average per year.
EPS 1Y (TTM)202.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%891.77%
Revenue 1Y (TTM)-6.19%
Revenue growth 3Y-3.19%
Revenue growth 5Y-0.96%
Sales Q2Q%-3.63%

3.2 Future

Based on estimates for the next years, MSTR will show a very strong growth in Earnings Per Share. The EPS will grow by 44.61% on average per year.
Based on estimates for the next years, MSTR will show a decrease in Revenue. The Revenue will decrease by -0.79% on average per year.
EPS Next Y-156.25%
EPS Next 2Y39.15%
EPS Next 3Y44.61%
EPS Next 5YN/A
Revenue Next Year-1.26%
Revenue Next 2Y1.06%
Revenue Next 3Y2.63%
Revenue Next 5Y-0.79%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MSTR Yearly Revenue VS EstimatesMSTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
MSTR Yearly EPS VS EstimatesMSTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 457.45 indicates a quite expensive valuation of MSTR.
MSTR's Price/Earnings is on the same level as the industry average.
MSTR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.30.
MSTR is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 457.45
Fwd PE N/A
MSTR Price Earnings VS Forward Price EarningsMSTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -500 -1K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MSTR Per share dataMSTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 -100

4.3 Compensation for Growth

A more expensive valuation may be justified as MSTR's earnings are expected to grow with 44.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.15%
EPS Next 3Y44.61%

More info and screens

0

5. Dividend

5.1 Amount

MSTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MICROSTRATEGY INC-CL A

NASDAQ:MSTR (7/11/2025, 8:00:02 PM)

After market: 433.3 -1.28 (-0.29%)

434.58

+12.84 (+3.04%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners50.01%
Inst Owner Change0.05%
Ins Owners0.18%
Ins Owner Change87.59%
Market Cap118.81B
Analysts81.11
Price Target489.6 (12.66%)
Short Float %9.41%
Short Ratio1.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)857.58%
Min EPS beat(2)-4213.73%
Max EPS beat(2)5928.88%
EPS beat(4)1
Avg EPS beat(4)52.49%
Min EPS beat(4)-4213.73%
Max EPS beat(4)5928.88%
EPS beat(8)3
Avg EPS beat(8)-279.81%
EPS beat(12)4
Avg EPS beat(12)-9128.41%
EPS beat(16)7
Avg EPS beat(16)-6875.11%
Revenue beat(2)0
Avg Revenue beat(2)-5%
Min Revenue beat(2)-6%
Max Revenue beat(2)-3.99%
Revenue beat(4)0
Avg Revenue beat(4)-7.02%
Min Revenue beat(4)-10.88%
Max Revenue beat(4)-3.99%
Revenue beat(8)1
Avg Revenue beat(8)-6.04%
Revenue beat(12)2
Avg Revenue beat(12)-4.59%
Revenue beat(16)3
Avg Revenue beat(16)-3.98%
PT rev (1m)5.67%
PT rev (3m)13.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)27.57%
EPS NY rev (1m)-3665.48%
EPS NY rev (3m)-3484.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.46%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-2.69%
Valuation
Industry RankSector Rank
PE 457.45
Fwd PE N/A
P/S 258.7
P/FCF N/A
P/OCF N/A
P/B 3.54
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.95
EY0.22%
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-103.08
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS1.68
BVpS122.63
TBVpS-36.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.16%
ROE -15.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.95%
FCFM N/A
ROA(3y)-18.83%
ROA(5y)-14.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.22%
GM growth 5Y-1.93%
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 87678.7%
Cap/Sales 6118.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z 6.86
F-Score2
WACC10.75%
ROIC/WACCN/A
Cap/Depr(3y)33259.4%
Cap/Depr(5y)26278.5%
Cap/Sales(3y)1735.12%
Cap/Sales(5y)1190.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)202.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%891.77%
EPS Next Y-156.25%
EPS Next 2Y39.15%
EPS Next 3Y44.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.19%
Revenue growth 3Y-3.19%
Revenue growth 5Y-0.96%
Sales Q2Q%-3.63%
Revenue Next Year-1.26%
Revenue Next 2Y1.06%
Revenue Next 3Y2.63%
Revenue Next 5Y-0.79%
EBIT growth 1Y-573.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.35%
EBIT Next 3Y81.44%
EBIT Next 5YN/A
FCF growth 1Y-10861.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2632.86%
OCF growth 3YN/A
OCF growth 5YN/A